FBIOX Mutual Fund

FBIOX Mutual Fund

NAV$27.26
See how much of FBIOX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Feb 28, 2026

Net Assets
$7.1B
Expense Ratio
0.62%
Dividend Yield (Current)
1.53%
Holdings
191
Inception Date
Dec 16, 1985
Fund Family
Fidelity Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+20.46%
1 Year+37.90%
3 Year+26.30%
5 Year+8.27%
10 Year+16.83%

Asset Allocation

Stocks: 96.66%
Cash: 2.57%
Other: 0.77%
See how much of FBIOX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ABBVAbbvie Inc.13.22%
KRYSKrystal Biotech Inc9.30%
GILDGilead Sciences8.77%
AMGNAmgen Inc.8.34%
ALNYAlnylam Pharmaceuticals Inc.3.09%
Top 10 Concentration: 54.60%Report Date: Feb 28, 2026
Download all 191 holdings for FBIOX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.53%
Latest Distribution
$1.10
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

FBIOX Mutual Fund Overview

FBIOX Mutual Fund (Fidelity Select Biotechnology Portfolio) is managed by Fidelity Investments (US) with $7.10B in net assets. FBIOX expense ratio is 0.62%, holding 191 positions across sectors including Health Care, Financials, Industrials. Inception date: 1985-12-16.

FBIOX performance shows a YTD return of 20.46%. The 1-year return is 37.90% and the 5-year return is 8.27%. FBIOX dividend yield stands at 1.53%.

FBIOX top holdings include Abbvie Inc. (13.2%), Krystal Biotech Inc (9.3%), Gilead Sciences (8.8%), Amgen Inc. (8.3%), Alnylam Pharmaceuticals Inc. (3.1%). Go to all FBIOX holdings, FBIOX sectors, or FBIOX dividends.

FBIOX can be compared against other funds. Use FBIOX overlap to find shared positions, or FBIOX vs another fund for a side-by-side view. FBIOX alternatives are available via the screener, along with tax-loss harvesting opportunities.